scPharmaceuticals Inc. (SCPH) Deferred Tax Assets, Valuation Allowance USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
scPharmaceuticals Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2017 to 2023.
  • scPharmaceuticals Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $73.2 M, a 23.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $73.2 M +$14.1 M +23.8% Dec 31, 2023 10-K 2024-03-13
Q4 2022 $59.1 M +$7.69 M +15% Dec 31, 2022 10-K 2024-03-13
Q4 2021 $51.4 M +$8.32 M +19.3% Dec 31, 2021 10-K 2024-03-13
Q4 2020 $43.1 M +$9.08 M +26.7% Dec 31, 2020 10-K 2022-03-22
Q4 2019 $34 M +$9.29 M +37.6% Dec 31, 2019 10-K 2021-03-23
Q4 2018 $24.7 M +$8.06 M +48.4% Dec 31, 2018 10-K 2020-03-24
Q4 2017 $16.7 M Dec 31, 2017 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.